Sign in Subscribe
Software industry

ICAP Ocean Tomo Licenses 7 IP Portfolios from Lawrence Livermore National Laboratory

Strategic Insights

— 1 min read

ICAP Ocean Tomo has been engaged to exclusively license 7 intellectual property portfolios owned by the Lawrence Livermore National Laboratory on behalf of Lawrence Livermore National Security, LLC. The portfolios contain a total of 118 issued patents cited by industry giants such as IBM, Intel, Siemens, GE, Abbott Laboratories, Pfizer, Microsoft, and Sony. The technology of the portfolios applies to various areas including semiconductor device fabrication, analytical instruments for biomedical research, surgical applications, MEMS, speech signal processing, fiber optics communication and manufacturing, and imaging in 3-D motion cameras.

Key Takeaways:

  • ICAP Ocean Tomo will license 7 intellectual property portfolios from Lawrence Livermore National Laboratory, with 118 issued patents in total.
  • The portfolios cover a range of technologies, including semiconductor device fabrication, biomedical research, and MEMS.
  • Industry giants such as IBM, Intel, Siemens, GE, Abbott Laboratories, Pfizer, Microsoft, and Sony have cited the patents in the portfolios.
  • The licensing will be conducted through ICAP Ocean Tomo's brokerage platform.
  • The technology portfolios have indicative pricing available upon request.
  • Lawrence Livermore National Laboratory is a national security laboratory with a mission to ensure national security and apply science and technology to important issues.
  • ICAP Ocean Tomo is the intellectual property brokerage division of ICAP, a leading interdealer broker and provider of post-trade services.
  • The transaction is expected to provide a "golden opportunity" to the intellectual property marketplace, according to ICAP Ocean Tomo President Dean Becker.

Statistics:

  • 118: The total number of issued patents in the 7 intellectual property portfolios.
  • 58: The number of patents in the semiconductor technology portfolio.
  • 18: The number of patents in the basic biomedical research portfolio.
  • 13: The number of patents in each of the surgical applications and speech signal processing portfolios.
  • 10: The number of patents in the MEMS portfolio.
  • 4: The number of patents in the fiber optics portfolio.
  • 2: The number of patents in the imaging portfolio.

Sources:

  • ICAP Ocean Tomo LLC
  • Lawrence Livermore National Laboratory
  • Blood Weekly via NewsRx.com (Copyright 2009)

Read more